G9a
[[File:Script error: No such module "InfoboxImage".|frameless|alt=]]
| Identifiers | |
|---|---|
| EC number | 2.1.1.- |
| CAS number | |
| Alt. names | |
| IntEnz | IntEnz view |
| BRENDA | BRENDA entry |
| ExPASy | NiceZyme view |
| KEGG | KEGG entry |
| MetaCyc | metabolic pathway |
G9a is a protein that in humans is encoded by the EHMT2 gene. G9a is a histone methyltransferase enzyme that specifically methylates the lysine 9 position of histone H3, a process that is associated with the transcriptional repression of genes. The activity of G9a is crucial for various biological processes, including embryonic development, cell differentiation, and the regulation of viral infections.
Function[edit | edit source]
G9a is primarily known for its role in epigenetics, where it modifies chromatin structure to regulate gene expression. The methylation of histone H3 at lysine 9 by G9a creates a marker that is recognized by other proteins involved in gene repression. This modification can lead to the formation of heterochromatin, a tightly packed form of DNA which often silences gene expression.
In addition to its role in chromatin dynamics, G9a has been implicated in other cellular processes such as DNA repair and cell cycle regulation. The enzyme's activity is regulated by various factors, including its interaction with other proteins and post-translational modifications.
Clinical Significance[edit | edit source]
Alterations in G9a activity and expression levels have been linked to several human diseases, particularly cancer. Overexpression of G9a has been observed in various types of cancer, where it can promote tumor growth and survival by silencing tumor suppressor genes. Consequently, G9a is considered a potential target for cancer therapy, with inhibitors of G9a being explored as therapeutic agents.
In addition to cancer, dysregulation of G9a activity has been associated with neurological disorders and developmental abnormalities. Research is ongoing to further understand the role of G9a in these conditions and to develop strategies for therapeutic intervention.
See Also[edit | edit source]
References[edit | edit source]
 | This enzyme-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
